Levalbuterol Tartrate Hfa Inhalation Aerosol, Metered
NDC Package 0591-2927-54
Package Information
Levalbuterol Tartrate Hfa Inhalation (levalbuterol tartrate) aerosols is levalbuterol tartrate HFA inhalation aerosol is contraindicated in patients with a history of hypersensitivity to levalbuterol, racemic albuterol, or any other component of Levalbuterol tartrate HFA inhalation aerosol. Reactions have included urticaria, angioedema, rash, bronchospasm, anaphylaxis, and oropharyngeal edema. This formulation utilizes a aerosol, metered delivery system. Marketed by Actavis Pharma, Inc., this product is identified by NDC 0591-2927 and is authorized under FDA application NDA021730.
Identification & Billing
- RxCUI: 745791 - levalbuterol 45 MCG/INHAL Metered Dose Inhaler, 200 Actuations
- RxCUI: 745791 - 200 ACTUAT levalbuterol 0.045 MG/ACTUAT Metered Dose Inhaler
- RxCUI: 745791 - levalbuterol 0.045 MG/ACTUAT Metered Dose Inhaler, 200 ACTUAT
- RxCUI: 745791 - levalbuterol 45 MCG/ACTUAT Metered Dose Inhaler, 200 ACTUAT
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 0591 - Actavis Pharma, Inc.
- 0591-2927 - Levalbuterol Tartrate Hfa Inhalation
- 0591-2927-54 - 1 INHALER in 1 CARTON / 200 AEROSOL, METERED in 1 INHALER
- 0591-2927 - Levalbuterol Tartrate Hfa Inhalation
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 0591-2927-54 identifies a specific commercial package of 1 inhaler in 1 carton / 200 aerosol, metered in 1 inhaler of Levalbuterol Tartrate Hfa Inhalation, a human prescription drug labeled by Actavis Pharma, Inc.. This aerosol, metered is formulated for oral use and contains levalbuterol tartrate as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Actavis Pharma, Inc. on October 03, 2016. The current certification is valid through December 31, 2026.
How is this Actavis Pharma, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 00591292754. Quantities are measured in per "gm or gram", products billed per gram are products measured by weight.. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.